Bio-Rad Laboratories, Inc. (BIO) has a market capitalization of $7.89B and trades at $292.23. The 52-week range is 211.43-343.12.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 10.5, Earnings Per Share (EPS) of $27.87, annual revenue of $2.58B.
The stock has a beta of 1.16, operates in the Healthcare sector.